Downloadable Flyer: Accelerate Your Nasal Spray ANDA Submission with Our IVBE Device Equivalence Package

Cormica’s IVBE Device Equivalence Package for nasal sprays is designed to meet FDA requirements efficiently through validated methodologies and lifecycle-based testing.

Our flyer outlines the complete package including:

  • Full scope of IVBE tests for nasal sprays
  • Recommended validated methods
  • Sample and batch requirements
  • Lifecycle testing stages

Download the flyer to see how our tailored in vitro bioequivalence (IVBE) testing solutions can accelerate your nasal spray’s path to FDA submission and approval.

Cormica’s global team of regulatory experts and GMP-accredited labs provide end-to-end ANDA support, from method development to stability and bioequivalence testing. We help you reduce complexity and accelerate time to market with proven strategies tailored to FDA expectations.

Explore Our Full ANDA Support Services for Generic Pharmaceutical Development

Download our supporting flyer on Analytical Support for Complex Pressurised Metered Dose Inhaler (pMDI)

Mockup of Cormica's IVBE Device Equivalence Package flyer for nasal sprays, featuring a testing methodology table and QR code for more information.

Type:

Published:

29/05/2025

Download:

We will email you the link to the PDF file.

Facebook
X
LinkedIn
Email
WhatsApp
Print

Related Resources or Articles

Other Cormica News, Events & Resources

Contact our Experts
Scroll to Top